Here are the S-3 shelf registrations from Citius Oncology, Inc. (CTOR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow CTOR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTOR filings page.
Citius Oncology, Inc. is registering up to 32,931,482 shares of common stock for resale by selling stockholders.
The registration covers (i) up to 25,555,556 shares issuable upon exercise of Purchaser Warrants at an exercise price of $0.90, (ii) up to 894,444 shares issuable upon exercise of Placement Agent Warrants at $1.125, (iii) up to 3,703,704 shares issuable upon conversion of up to $4.0 million of term loans at a conversion price of $1.08, and (iv) up to 2,777,778 shares issuable upon exercise of Lender Warrants at $0.90.
The shares are being registered to satisfy registration rights and will be sold from time to time by the identified selling stockholders; the Company will not receive proceeds from resales but would receive proceeds from any cash exercise of the Warrants. Shares outstanding were 92,981,204 before this registration and would be 125,912,686 after full exercise as assumed in the prospectus.